prolactinoma cell line; intracellular Ca 2ϩ ; L-type channel; exocytosis GH3/B6 CELLS ARE A CLONAL LINE of rat lactotrophs that can release the polypeptide hormone prolactin (PRL) in response to different stimuli. Whereas some mechanisms cause slow, synthesis-based release of PRL, others allow for rapid release of PRL from storage vesicles. Estradiol (E 2 ) has been shown to regulate synthesis of PRL via genomic mechanisms (13) . In addition, genomic estrogenic effects influence PRL release through protein upregulation of L-type voltage-dependent Ca 2ϩ channel proteins required for exocytosis and through upregulation of PKC, which influences the generation of Ca 2ϩ currents and exocytosis by phosphorylation (33) . However, in addition to classic genomic (protein synthetic) effects, physiological concentrations of E 2 can rapidly stimulate a variety of second-messenger pathways in diverse cell types (30, 31) . These include generation of cAMP and nitric oxide, activation of kinases (MAPK, phosphatidylinositol 3-kinase), and elevation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) levels (3, 8, 12, 18, 22, 27, 28) . Rapid [Ca 2ϩ ] i level increases elicited by E 2 can come from intracellular stores and be initiated by capacitative Ca 2ϩ entry through store-operated Ca 2ϩ channels in mouse neurons (2) , breast cancer cells (17) , human endometrial cells, and rat distal colon (9) . E 2 can also modulate voltagedependent Ca 2ϩ channel activity in macrophages (1) and vascular smooth muscle cells (19) . In the GH3/B6 cell line, rapid effects of E 2 on membrane excitability have also been observed; E 2 can activate Ca 2ϩ currents by increasing the action potential frequency or by the reversal of dopamine-mediated inhibition (10, 11 ). E 2 is also able to increase PRL secretion at 10 min in the GH3/B6 cell line (34) , at 1-5 min in our sublines expressing increased amounts of membrane estrogen receptor-␣ (mER␣; Refs. 24 -26) , and within 10 min in lactotroph primary cultures (6) . Dufy et al. (11) demonstrated the similarity between E 2 -and thyroid hormone (TRH)-regulated effects on Ca 2ϩ currents through voltage-dependent Ca 2ϩ channels. TRH, as well as other neuropeptides (VIP family proteins, angiotensin), is able to produce a rapid PRL release from lactotrophs, and all of these peptides act via receptors coupled to different types of G proteins (G q , G i , G s , and so forth) on the plasma membranes of lactotrophs. Activation of G proteins, in turn, leads to an increase in PLC activity, which produces inositol trisphosphate that binds to a receptor on the endoplasmic reticulum and releases Ca 2ϩ . Voltage-dependent Ca 2ϩ channel activity can also be modulated by phosphorylation of the channel's subunits via PKC or, in the case of cAMP production, PKA (13) . Therefore, Ca 2ϩ levels are raised in this cell type via a variety of specific pathways and mechanisms.
In the present study, using GH3/B6/F10 (F10) and GH3/B6/D9 (D9) sublines enriched and depleted for mER␣, respectively (23), we examined the role of this membrane steroid receptor in these processes. Our goal was to link the presence of the mER␣ receptor directly to specific mechanistic pathways. Our more detailed examination of the mechanism of E 2 -induced Ca 2ϩ mobilization linked to this receptor also addresses the extent to which Ca 2ϩ elevations are responsible for PRL secretion.
MATERIALS AND METHODS
Reagents. Phenol red-free DMEM was purchased from Mediatech (Herndon, VA). Horse serum was from GIBCO Invitrogen (Carlsbad, CA); defined-supplemented calf sera and fetal bovine sera were from Hyclone (Logan, UT). We purchased paraformaldehyde and glutaraldehyde from Fischer Scientific (Pittsburgh, PA). Nifedipine, thapsigargin, and 2,5-di-(t-butyl)-1,4-hydroquinone (tBHQ) were purchased from Calbiochem (San Diego, CA), and fura 2-AM was from Molecular Probes (Eugene, OR). From the National Institute of Diabetes and Digestive and Kidney Disease's National Hormone and Pituitary Program (NIDDK, Baltimore, MD), we purchased rat PRL-RP-3 standard and anti-rPRL-s-9.
125 I-labeled rat PRL was from PerkinElmer (Wellesley, MA). The ER antagonist ICI 182 780 was purchased from Tocris (Ellisville, MO) or Zeneca Pharmaceuticals (Cheshire, UK). The C542 antibody, which recognizes the COOH terminus of ER␣, was from StressGen (Victoria, BC, Canada). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO). For the E 2-peroxidase (E2-P) conjugate purchased from Sigma, we administered 10 nM on the basis of the E2 concentration in the complex. To eliminate free E2 molecules from the E2-P reagent, it was centrifuged through a Millipore filter (cutoff mol wt 10,000) just before use in these assays.
Cell culture. The GH3/B6/F10 and GH3/B6/D9 clonal rat prolactinoma cell lines were further selected for high and low expression of mER␣, respectively, using C542 antibody according to immunopanning methods previously reported (26) . Cells were routinely cultured in DMEM containing 12.5% horse serum, 2.5% defined-supplemented calf serum, and 1.5% fetal bovine serum. For individual experiments, cells were deprived of steroids for 48 h after plating by substitution of culture media with DMEM containing 5 g/ml insulin and transferrin and 5 ng/ml sodium selenite plus 0.1% BSA, 20 used in Ringer solution containing high CaCl2 (10 mM). In the Ca 2ϩ -free solution experiments, we added E2 quickly after the solution change (within 5 min) to prevent response changes due to Ca 2ϩ leakage from intracellular stores. E 2 and other reagents were administered with a microperfusion pump system (Bioptechs, Butler, PA) at a rate of 2 ml/min. The dead time between the vials of treatment solution and the cell chamber (Molecular Probes) was 20 s; the solution was pumped as close to the cells as possible. All experiments were done at RT. Imaging was performed using a TE200-IUC Quantitative Fluorescence Live-Cell and Multidimensional Imaging System equipped with a Nikon EPI 200 fluorescence microscope and a digital monochrome-cooled charge-coupled device Roper Coolsnap HQ camera (Roper Scientific, Tucson, AZ). Signals were collected from regions of interest corresponding to a single cell with a ϫ40 objective (1.3 NA) using the MetaFluor program (Universal Imaging, Downingtown, PA). Background measurements were made from an area without cells. Signals were obtained in dual excitation mode (340/ 380 nm), and the [Ca 2ϩ ]i was calculated as a ratio (R340/380) of emission data collected at 510 nm after background subtraction (15) . To quantitate the degree of Ca 2ϩ elevation, data were represented as a change in fluorescence ratio (R Ϫ R0) during a 5-min treatment period, normalized to the basal [Ca 2ϩ ]i level (R0). PRL release. GH3/B6 sublines (5 ϫ 10 5 cells/well) were plated in poly-D-lysine-coated six-well plates. Just before each experiment, the medium was removed and new DMEM-0.1% BSA containing E 2 or vehicle (control) was added. The cells were incubated for 3, 6, 10, or 15 min at 37°C and then centrifuged at 300 g for 5 min. The supernatant was collected and stored at Ϫ20°C. Each experiment was repeated four times.
PRL RIA. Concentrations of PRL in the media of GH3/B6 sublines were determined using components of the rat PRL RIA kit from the NIDDK. Briefly, RIA buffer (80% PBS, 20% DMEM, 2% normal rat serum), 100 l of cold standard or unknown sample, 125 I-labeled rat PRL at 15,000 counts/tube (diluted in RIA buffer), and rPRL-s-9 antiserum (final dilution of 1:437,500 in RIA buffer) were combined and incubated overnight with shaking at 4°C. Anti-rabbit IgG (Sigma R-0881, 1:9 dilution) was added, and the samples were further incubated in a shaker for 2 h at RT. One milliliter of polyethylene glycol solution (Sigma P-6667; 1.2 M PEG, 50 mM Tris, pH 8.6) was then added, and the samples were incubated for an additional 15 min at RT. The samples were then centrifuged at 4,000 g for 10 min at 4°C, the supernatant was decanted, and the pellet was counted in a 1470 Wizard gamma counter. PRL concentrations were normalized to cell number [determined by the crystal violet (CV) assay].
CV assay. This procedure was used to normalize the PRL concentration to cell number (5) . Briefly, after collection of the supernatant, cells were fixed in 2% paraformaldehyde-0.1% glutaraldehyde for 30 min at RT. They were then washed with water and allowed to dry completely. A 0.1% CV solution was then added to each well, and the plates were incubated for 30 min at RT. Washing and drying were repeated as before. The dye was extracted with 10% acetic acid solution and read at A 590 nm on a 1420 Wallac microplate reader (Perkin-Elmer, Boston, MA). Statistics. Data were compared for significance of differences using a one-way ANOVA test, followed where appropriate by a MannWhitney test (accepting significance at P Յ 0.05). The Sigma Stat program was used for these calculations (version 3; Jandel Scientific, San Rafael, CA).
RESULTS

[Ca 2ϩ
] i changes due to E 2 action. The basal [Ca 2ϩ ] i level in the F10 cell line was measured at an average of 103.6 Ϯ 20 nM; ϳ30% of cells displayed spontaneous [Ca 2ϩ ] i oscillations, and the rest of cells were silent (Fig. 1A) . However, E 2 administration rapidly (within 1 min) increased the amplitude and frequency of Ca 2ϩ oscillation and produced significant effects even at the low concentration of 10 Ϫ12 M (Fig. 1B) . About 70% of the cells responded to the hormone. Among those responders, ϳ40% were spontaneously active in the 5 min before hormone application, and ϳ60% were silent without oscillation during this time. Vehicle (EtOH) treatment at 0.0001% did not produce any changes in basal [Ca 2ϩ ] i levels (data not shown). The averaging of the traces from individual cells (Fig. 1C) produced an apparent lessening in the amplitude of the Ca 2ϩ response to E 2 due to the misalignment of peaks, but increased frequency of responses were still clearly visible over the averaged cell population. Ca 2ϩ spikes remained consistent for the entire time of E 2 action (5 min) and continued to be present for a period of time during washing with PBS. However, the E 2 effect on [Ca 2ϩ ] i was reversible, taking ϳ5 min to wash out and cease to affect Ca 2ϩ activity (Fig. 1D ). Increasing the E 2 concentration from 10 Ϫ12 to 10 Ϫ8 M sequentially did not produce a desensitization in the Ca 2ϩ response (Fig. 1B, trace) but increased the response in a dose-dependent manner when the response values were calculated by looking at the increase in Ca 2ϩ levels over background (R Ϫ R 0 /R 0 , calculated for each cell before averaging the values; Fig. 1C,  inset) . Although D9 (mER␣ depleted) cells showed a low spontaneous Ca 2ϩ activity similar to that of F10 cells, E 2 administration did not change Ca 2ϩ levels, even at the highest (10 Ϫ8 M) hormone concentration (Fig. 2, A, B, and inset) . Again, the different phasing of the composite cell traces gave the appearance of higher frequency activations in Fig. 2B , but this did not correspond to any dose effect of E 2 (inset). The cell-impermeant E 2 analog, E 2 -P, was able to produce a more intensive [Ca 2ϩ ] i response compared with E 2 . However, the amplitude of this Ca 2ϩ response was slightly decreased on application of higher hormone concentrations (Fig. 3, A, B -ATP pump blockers thapsigargin (Tg) and tBHQ (which are irreversible and reversible, respectively). Because of emptying of Ca 2ϩ from the intracellular stores, these reagents were able to significantly increase [Ca 2ϩ ] i levels (Fig. 4) but did not affect the cell's subsequent response to E 2 . After the initial E 2 application, two subsequent treatments with Tg ensured complete depletion of the Tgsensitive intracellular Ca 2ϩ stores, demonstrated by no further Ca 2ϩ elevation by the second Tg application (Fig. 4B) . The amplitudes of the first and second (post-Tg) Ca 2ϩ responses to E 2 were not significantly different from each other.
To test the involvement of extracellular Ca 2ϩ in hormonestimulated signaling, we removed Ca 2ϩ from the extracellular solution by chelation (Fig. 5, A and B channel blocker nifedipine (Fig. 5, C and D) . The cells were first tested for their ability to respond to E 2 (10 Ϫ8 M). Then, nifedipine was perfused onto the cells alone, followed by nifedipine plus E 2 . This blocking agent was able to significantly block spontaneous Ca 2ϩ oscillations after hormone washout as well as prevent E 2 -induced [Ca 2ϩ ] i elevation. Although 1 M was effective, a more pronounced blocking effect was observed at 10 M.
PRL release is due to E 2 action via membrane ER␣. GH3 cell sublines with enriched and depleted membrane ER␣ levels (F10 and D9 cells, respectively) were tested for their ability to rapidly release PRL in response to E 2 . To determine that both cell lines had equivalent levels of PRL stored and ready for release, 20 mM KCl was applied. This treatment causes massive cellular depolarization and consequent activation of voltage-dependent Ca 2ϩ channels, which results in significant [Ca 2ϩ ] i increases. This will usually result in exocytosis in neuroendocrine cells. Both cell lines were able to release a Ca 2ϩ -sensitive PRL pool after KCl depolarization (compare Fig. 6, A and B) . E 2 induced a rapid (within 3 min after application) PRL secretion in F10 cells (Fig. 6A) , as expected (26) . Released PRL stayed constant at longer test times up to 15 min, indicating that all of the releasable pool was quickly dumped. However, D9 cells were not sensitive to the E 2 application (Fig. 6B ), even though they had plentiful KCl- releasable PRL. All E 2 concentrations tested were effective in PRL release in F10 cells (Fig. 6C) , but with the bimodal dose response pattern similar to that seen previously (32) .
At 10 Ϫ8 M, E 2 produced a significantly higher PRL release from F10 cells at 3 min than did KCl (Fig. 7 ), although the Ca 2ϩ level elevation was much higher in the case of KCl. Therefore, Ca 2ϩ elevation could not be solely responsible for PRL release. However, blocking the L-type voltage-dependent Ca 2ϩ channel with nifedipine (10 M) totally prevented E 2 -induced PRL release measured at 3 min (Fig. 8) . Therefore, the Ca 2ϩ increase seems to be a necessary initiator of PRL release, but subsequent E 2 -induced mechanisms that influence exocytosis events may be Ca 2ϩ independent. Hormone and receptor specificity of the estrogen-induced [Ca 2ϩ ] i and PRL responses. The 17␤-E 2 stereoisomer of 17␣-E 2 was unable to stimulate [Ca 2ϩ ] i changes or PRL release in F10 cells (Fig. 9) . The synthetic antagonist of estrogen receptor ICI 182 780 prevented rapid E 2 -induced [Ca 2ϩ ] i increases and PRL secretion and did not produce any changes in PRL secretion or basal Ca 2ϩ levels when used alone.
DISCUSSION
The effects of E 2 on Ca 2ϩ levels and PRL release in GH3/B6 cell sublines strongly depends on the presence of mER␣ on the cell's plasma membrane, as cells with very low mER␣ expression (the D9 subline) did not respond to E 2 compared with F10 cells (which have high levels of mER␣). Additional evidence for the participation of mER␣ was the response to the cellimpermeant analog of E 2 , E 2 -P. A more pronounced [Ca 2ϩ ] i elevation caused by this impeded ligand may be explained by the reagent's continued presence on the plasma membrane (where it may continue to stimulate) compared with free E 2 , which can readily diffuse inside the cells rapidly after application. Alternatively, because some conjugates may contain more than one E 2 molecule, this reagent may artificially cluster receptors by binding to more than one at a time, amplifying the signal. The slight desensitization seen after concentrationdependent E 2 -P "overstimulation" can probably be explained by similar reasoning. Very low (lower than nanomolar) E 2 concentrations produced both Ca 2ϩ elevation and PRL release, so these responses are physiologically relevant. Inhibition of these E 2 -induced effects by the ER antagonist ICI 182 780 and the lack of stimulation by stereoisomer 17␣-E 2 provide additional evidence for E 2 action through a known ER protein.
Using the fluorescent dye fura 2, we confirmed that extra- (29) and that, in lactotrophs isolated from pituitaries of male rats (6), PRL secretion was not sensitive to extracellular Ca 2ϩ removal. However, in our study, the similar amplitude of E 2 -induced Ca 2ϩ increase before and after Tg application demonstrated an independence of Ca 2ϩ response from Tg-sensitive intracellular stores. This discrepancy might be explained by the differences between primary cultures vs. established cancer cell lines.
Consistent with our studies is a previous investigation of E 2 effects on electrical membrane properties in the parent GH3/B6 cell line, done with intracellular microelectrode recording (11) , showing that E 2 can elicit action potentials that were sensitive to the Ca 2ϩ channel blocker D600, an earlier and less selective blocker. However, the possible participation of intracellular Ca 2ϩ stores in the E 2 -induced membrane signaling and PRL release response was not investigated in these early studies.
In our studies, the selective L-type Ca 2ϩ channel blocker dihydropyridine nifedipine was able to inhibit the E 2 -stimulated [Ca 2ϩ ] i increase in a concentration-dependent manner. These results are consistent with the recent findings that the GH3/B6 parent cell line expresses P-, Q-, and low amounts of T-but primarily L-type voltage-dependant Ca 2ϩ channels (14) . Higher concentrations of nifedipine (10 M) were shown to inhibit ϳ90% of the L-type Ca 2ϩ channel currents while being ineffective in blocking other Ca 2ϩ channel subtypes in one study (14) . However, others have shown that P-and Q-type Ca 2ϩ channels in melanotrophs (which have the same pituitary origin as lactotrophs) are extremely sensitive to dihydropyriridines (with half-maximal blockage at 200 -500 nM; Ref. 21) . Therefore, these Ca 2ϩ channels, in addition to the L-type, could be involved in E 2 stimulations, but this question needs further clarification regarding the sensitivity of specific channel subtypes to nifedipine.
The precise protein interactions or signaling cascades involved in the regulation of voltage-dependent Ca 2ϩ channels by E 2 via a membrane ER remain to be determined. The structure/conformation of mERs on the plasma membrane and their repertoire of interacting proteins are not yet known. Voltage-dependent Ca 2ϩ channels may be opened by depolarization due to the inactivation of K ϩ currents by E 2 . It was previously shown that E 2 at nanomolar concentrations can rapidly increase a cell's excitability by inhibition of A-type K ϩ currents in gonadotropin-releasing neurons (7) and closing of K ϩ (ATP) channels in pancreatic ss cells (22) . Another possible mechanism for voltage-dependent Ca 2ϩ channel regulation is the phosphorylation of channel subunits by PKC or PKA (16, 33) , which can be activated in other cell types via E 2 action. Voltage-dependent Ca 2ϩ channel opening is thought to be the main trigger for PRL release, corresponding to the classic model for exocytosis from the literature (4). However, for neuroendocrine cells, generally three different stages of secretion have been observed. The most rapid (within 100 ms) stage involves readily releasable pools contained in vesicles that are fused with the plasma membrane, causing release of PRL, and are regulated largely via Ca 2ϩ channel activity. A second, slower stage involves a docked vesicle pool interacting with a membrane fusioninducing protein complex associated with the membrane [N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex]. This pool can be regulated by Ca 2ϩ level changes but also by PKC, ATP, cAMP, and PKA. A third reserve pool contains vesicles that are not yet docked but are available for the subsequent steps. Recruitment of these vesicles to the docked pools can be triggered by the stimuli above, or by an increase in GTP levels (20) . Therefore, it is possible that E 2 , using other signaling pathways, can induce recruiting actions in these second and third vesicle populations in our model. This would account for maximal Ca 2ϩ levels (achieved with KCl application) causing only moderate (submaximal) PRL release. The discrepancy between high Ca 2ϩ and low PRL responses after 10
Ϫ9 M E 2 stimulation (Fig. 1C , inset, vs. Fig. 6C , respectively) may be explained similarly. However, because blocking of Ca 2ϩ channels with nifedipine completely abolishes the PRL release response, the Ca 2ϩ -releasable pool may have to be expelled before these other E 2 -stimulated mechanisms are permitted to act.
In summary, E 2 is a potent regulator of these membraneinitiated neuroendocrine secretory functions, and a membrane form of ER␣ is involved in rapid PRL secretion. However, Ca 2ϩ is probably only part of the mechanism responsible for this response. Details about the membrane machineries and their mode of interaction with membrane receptors for estrogens are still lacking. The portions of the signaling cascades examined in these studies (Ca 2ϩ level changes leading to PRL secretion) are only part of the web of signaling intermediates that define estrogenic responses in these cells.
